Minax XL

País: Nueva Zelanda

Idioma: inglés

Fuente: Medsafe (Medicines Safety Authority)

Ingredientes activos:

Metoprolol succinate 23.75mg

Disponible desde:

Viatris Limited

Designación común internacional (DCI):

Metoprolol succinate 23.75 mg

Dosis:

23.75 mg

formulario farmacéutico:

Modified release tablet

Composición:

Active: Metoprolol succinate 23.75mg Excipient: Colloidal silicon dioxide Ethylcellulose Hypromellose Macrogol 400 Macrogol 6000 Microcrystalline cellulose Opadry white 32K58900 Purified water Sodium stearyl fumarate

tipo de receta:

Prescription

Fabricado por:

CTX Life Sciences Pvt. Limited

indicaciones terapéuticas:

· Hypertension. To reduce blood pressure and to reduce the risk of cardiovascular and coronary mortality (including sudden death), and morbidity. · Paediatric hypertension.

Resumen del producto:

Package - Contents - Shelf Life: Blister pack, OPA/Al/PVC/Al or PVC/Aclar/Al - 15 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, OPA/Al/PVC/Al or PVC/Aclar/Al - 30 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE with PP screw cap and desiccant - 30 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE with PP screw cap and desiccant - 500 tablets - 24 months from date of manufacture stored at or below 25°C

Fecha de autorización:

2013-01-07